Total Payments
$8,302
2024 Payments
$210.11
Companies
31
Transactions
339
Medicare Patients
14,390
Medicare Billing
$3.0M
Payment Breakdown by Category
Food & Beverage$8,104 (97.6%)
Consulting$150.00 (1.8%)
Education$47.71 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,104 | 326 | 97.6% |
| Consulting Fee | $150.00 | 1 | 1.8% |
| Education | $47.71 | 12 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,369 | 55 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,047 | 24 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $870.32 | 35 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $846.69 | 41 | $0 (2020) |
| GlaxoSmithKline, LLC. | $789.45 | 44 | $0 (2020) |
| Lilly USA, LLC | $548.70 | 28 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $352.93 | 9 | $0 (2017) |
| PFIZER INC. | $339.03 | 24 | $0 (2020) |
| Alkermes, Inc. | $298.59 | 3 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $277.72 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.11 | 5 | Mylan Specialty L.P. ($122.39) |
| 2023 | $324.53 | 5 | Neurocrine Biosciences, Inc. ($130.74) |
| 2022 | $183.37 | 8 | Neurocrine Biosciences, Inc. ($122.17) |
| 2021 | $322.28 | 13 | Teva Pharmaceuticals USA, Inc. ($153.13) |
| 2020 | $968.27 | 33 | Teva Pharmaceuticals USA, Inc. ($553.46) |
| 2019 | $1,880 | 83 | Janssen Pharmaceuticals, Inc ($633.70) |
| 2018 | $1,595 | 78 | Novartis Pharmaceuticals Corporation ($415.34) |
| 2017 | $2,818 | 114 | Novartis Pharmaceuticals Corporation ($568.80) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Central Nervous System | ||||||
| 09/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Central Nervous System | ||||||
| 06/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $122.39 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Neuropsychiatry | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Neuropsychiatry | ||||||
| 09/07/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: Neuropsychiatry | ||||||
| 06/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $102.42 | General |
| Category: Diabetes | ||||||
| 03/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $91.37 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $97.31 | General |
| Category: Neuropsychiatry | ||||||
| 11/10/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $83.17 | General |
| Category: Neuropsychiatry | ||||||
| 10/25/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Neuropsychiatry | ||||||
| 06/23/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Central Nervous System | ||||||
| 06/02/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Neuropsychiatry | ||||||
| 06/02/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: Neuropsychiatry | ||||||
| 05/19/2022 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 03/28/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Inflammation | ||||||
| 10/27/2021 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Diabetes | ||||||
| 10/13/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Central Nervous System | ||||||
| 07/01/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Central Nervous System | ||||||
| 06/05/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Central Nervous System | ||||||
| 05/14/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Central Nervous System | ||||||
| 05/06/2021 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 6,014 | 35,496 | $4.3M | $1.6M |
| 2022 | 13 | 4,618 | 16,847 | $1.7M | $816,380 |
| 2021 | 5 | 1,569 | 4,271 | $373,595 | $248,192 |
| 2020 | 6 | 2,189 | 5,943 | $513,355 | $334,738 |
Total Patients
14,390
Total Services
62,557
Medicare Billing
$3.0M
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 1,086 | 6,312 | $555,835 | $397,452 | 71.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 728 | 8,088 | $1.7M | $326,343 | 19.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 674 | 7,240 | $582,490 | $240,113 | 41.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 728 | 4,390 | $614,600 | $229,499 | 37.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 706 | 4,117 | $413,890 | $166,261 | 40.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 472 | 2,312 | $173,072 | $100,608 | 58.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 340 | 401 | $82,206 | $62,355 | 75.9% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 411 | 1,609 | $88,800 | $53,484 | 60.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 219 | 246 | $30,225 | $21,559 | 71.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 154 | 164 | $26,298 | $18,589 | 70.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 164 | 174 | $22,754 | $17,898 | 78.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 80 | 140 | $29,710 | $4,162 | 14.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 80 | 84 | $11,760 | $3,624 | 30.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Facility | 2023 | 60 | 105 | $8,400 | $2,701 | 32.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Facility | 2023 | 69 | 71 | $7,100 | $1,826 | 25.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $1,837 | $1,538 | 83.7% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $1,490 | $1,083 | 72.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Facility | 2023 | 16 | 16 | $1,174 | $706.08 | 60.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 987 | 4,155 | $364,474 | $234,548 | 64.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 447 | 2,661 | $306,136 | $109,697 | 35.8% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 503 | 2,715 | $149,915 | $98,070 | 65.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 447 | 1,576 | $220,645 | $85,687 | 38.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 408 | 2,263 | $201,810 | $78,467 | 38.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 424 | 1,521 | $165,587 | $65,053 | 39.3% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 504 | 579 | $93,132 | $61,000 | 65.5% |
About Dr. Deepesh Patel, M.D
Dr. Deepesh Patel, M.D is a Internal Medicine healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720022486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepesh Patel, M.D has received a total of $8,302 in payments from pharmaceutical and medical device companies, with $210.11 received in 2024. These payments were reported across 339 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($8,104).
As a Medicare-enrolled provider, Patel has provided services to 14,390 Medicare beneficiaries, totaling 62,557 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Poughkeepsie, NY
- Active Since 06/15/2006
- Last Updated 09/30/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720022486
Products in Payments
- ENTRESTO (Drug) $1,047
- XARELTO (Drug) $789.89
- AUSTEDO (Drug) $720.07
- INVOKANA (Drug) $579.01
- APTIOM (Drug) $350.19
- TOUJEO (Drug) $314.22
- LONHALA MAGNAIR (Drug) $292.22
- INGREZZA (Drug) $277.72
- TRULICITY (Drug) $258.01
- TRELEGY ELLIPTA (Drug) $243.47
- NUEDEXTA (Drug) $232.14
- ANORO (Drug) $208.25
- OFEV (Drug) $189.93
- VRAYLAR (Drug) $155.42
- LYRICA (Drug) $150.79
- Aristada 441 mg (Drug) $125.00
- YUPELRI (Drug) $122.39
- BREO (Drug) $119.00
- CHANTIX (Drug) $116.30
- LATUDA (Drug) $104.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Poughkeepsie
Dr. Misha Kucherov, Md, MD
Internal Medicine — Payments: $33,268
Internal Medicine $33,268
Dr. Dina Abi Fadel, M.d, M.D
Internal Medicine — Payments: $30,065
Internal Medicine $30,065
Dr. David Cho, M.d, M.D
Internal Medicine — Payments: $24,781
Internal Medicine $24,781
Mrs. Sumita Mazumdar, M.d, M.D
Internal Medicine — Payments: $22,116
Internal Medicine $22,116
Dr. Gopa Rahman, Md, MD
Internal Medicine — Payments: $15,707
Internal Medicine $15,707
Dr. Satyanarayana Narasimhadevara, Md, MD
Internal Medicine — Payments: $12,985
Internal Medicine $12,985